Crossref
The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer
Oncomedicine · 2018
DOI: 10.7150/oncm.21294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncomedicine, 2018. Verfasst von Ryo Inose und 5 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Inose, R., Takahashi, K., Yoshimura, N., Kawaguchi, T., Takada, M., & Nagayama, K. (2018). The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer. Oncomedicine. https://doi.org/10.7150/oncm.21294
Vancouver
Inose R, Takahashi K, Yoshimura N, Kawaguchi T, Takada M, Nagayama K. The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer. Oncomedicine. 2018. doi:10.7150/oncm.21294
BibTeX
@article{Inose2018,
author = {Inose, Ryo and Takahashi, Katsuyuki and Yoshimura, Naruo and Kawaguchi, Tomoya and Takada, Mitsutaka and Nagayama, Katsuya},
title = {The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients with Non-Small Cell Lung Cancer},
journal = {Oncomedicine},
year = {2018},
doi = {10.7150/oncm.21294}
}
EUVIMED